Review: taking Morphine sulfate and Dilantin together


Summary

Drug interactions are reported among people who take Morphine sulfate and Dilantin together. This review analyzes the effectiveness and drug interactions between Morphine sulfate and Dilantin. It is created by eHealthMe based on reports of 887 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Morphine sulfate and Dilantin >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Morphine Sulfate

Morphine sulfate has active ingredients of morphine sulfate. It is often used in pain. (latest outcomes from Morphine sulfate 20,839 users)

Dilantin

Dilantin has active ingredients of phenytoin sodium. It is often used in convulsion. (latest outcomes from Dilantin 18,828 users)

On Aug, 22, 2016

887 people who take Morphine Sulfate, Dilantin are studied.


Number of reports submitted per year:

Morphine sulfate and Dilantin drug interactions.

Drug effectiveness over time:

Morphine Sulfate:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 100.0% - (1 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Dilantin:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 100.0% - (1 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Morphine Sulfate:
  • female: 100.0% - (1 of 1 people)
  • male: 0.0% - (0 of 0 people)
Dilantin:
  • female: 100.0% - (1 of 1 people)
  • male: 0.0% - (0 of 0 people)

Drug effectiveness by age:

Morphine Sulfate:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 100.0% - (1 of 1 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)
Dilantin:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 100.0% - (1 of 1 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • stevens-johnson syndrome
  • convulsion
  • hypotension
  • respiratory failure
  • haemorrhage
  • bk virus infection
  • cystitis haemorrhagic
  • cytomegalovirus infection
  • dehydration
  • hyperbilirubinaemia
1 - 6 months:
  • stevens-johnson syndrome
  • asthma
  • thrombocytopenia
  • arthralgia
  • blood creatinine increased
  • convulsion
  • death
  • difficulty in walking
  • drug eruption
  • drug ineffective
6 - 12 months:
  • dyspnoea
  • pneumonia
  • dehydration
  • drug hypersensitivity
  • lethargy
  • mental status changes
  • renal failure acute
  • rhabdomyolysis
  • sedation
  • alanine aminotransferase increased
1 - 2 years:
  • convulsion
  • interstitial lung disease
  • pneumonitis
  • agitation
  • cardiac failure congestive
  • death
  • dizziness (excl vertigo)
  • erythema
  • fabry's disease
  • fall
2 - 5 years:
  • angina pectoris
  • arthritis
  • hepatic enzyme increased
  • narcolepsy
  • oedema peripheral
  • fall
  • insomnia
  • loss of consciousness
  • morphoea
  • aggression
10+ years:
  • abdominal pain upper
  • anticonvulsant drug level below therapeutic
  • balance disorder
  • convulsion
  • dehydration
  • dizziness
  • drug level increased
  • fall
  • malaise
  • scapula fracture
not specified:
  • convulsion
  • pain
  • nausea
  • osteonecrosis of jaw
  • back pain
  • osteoarthritis
  • anaemia
  • fall
  • oedema peripheral
  • dyspnoea

Most common drug interactions by gender *:

female:
  • pain
  • convulsion
  • nausea
  • osteonecrosis of jaw
  • pain in jaw
  • fall
  • pain in extremity
  • anaemia
  • oedema peripheral
  • back pain
male:
  • convulsion
  • hypotension
  • pain
  • back pain
  • pyrexia
  • pneumonia
  • neuropathy peripheral
  • nausea
  • osteoarthritis
  • osteonecrosis of jaw

Most common drug interactions by age *:

0-1:
  • ascites
  • blood bilirubin increased
  • grand mal convulsion
  • liver function test abnormal
  • acute circulatory failure
  • angioedema
  • angioneurotic oedema
  • apnoea
  • atrioventricular block
  • blister
2-9:
  • stevens-johnson syndrome
  • ascites
  • stevens johnson syndrome
  • cerebral infarction
  • angioneurotic oedema
  • blister
  • stridor
  • gastrointestinal haemorrhage
  • graft versus host disease
  • stomatitis
10-19:
  • atrioventricular block complete
  • ventricular extrasystoles
  • acute graft versus host disease
  • alanine aminotransferase increased
  • aphasia
  • aspartate aminotransferase increased
  • blood creatine phosphokinase increased
  • blood pressure decreased
  • bronchopulmonary aspergillosis
  • cardiac arrest
20-29:
  • pain
  • dry skin
  • extremity contracture
  • hyperkeratosis
  • mobility decreased
  • nephrogenic systemic fibrosis
  • oedema
  • peripheral ischaemia
  • peroneal nerve palsy
  • skin depigmentation
30-39:
  • headache
  • hypotension
  • pain
  • agitation
  • torsade de pointes
  • muscular weakness
  • ventricular extrasystoles
  • oedema peripheral
  • blood creatine phosphokinase increased
  • blood magnesium decreased
40-49:
  • sepsis
  • mucosal inflammation
  • back pain
  • convulsion
  • deep vein thrombosis
  • osteonecrosis of jaw
  • hypotension
  • pyrexia
  • fall
  • dizziness
50-59:
  • osteoarthritis
  • convulsion
  • osteonecrosis of jaw
  • anaemia
  • neuropathy peripheral
  • nausea
  • dyspnoea
  • pain in jaw
  • arthralgia
  • pain in extremity
60+:
  • pain
  • confusional state
  • dysphagia
  • convulsion
  • nausea
  • osteomyelitis
  • pneumonia
  • anxiety
  • back pain
  • depression

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Morphine sulfate and Dilantin?

Can you answer these questions?

More questions for: Morphine sulfate, Dilantin

You may be interested in these reviews

More reviews for: Morphine sulfate, Dilantin

On eHealthMe, Morphine sulfate (morphine sulfate) is often used to treat pain. Dilantin (phenytoin sodium) is often used to treat convulsion. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.